Hepatitis C

The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions.

The objectives of the Drug-related infectious diseases (DRID) network are to share the latest developments on drug-related infectious diseases in Europe and to identify steps needed to improve the production, availability and use of public health-oriented information at the European level. This...

This manual provides a step-by-step guide for those involved in planning and managing infectious diseases and drug services, focusing on how to identify barriers to and opportunities for improving provision of HCV testing and access to treatment for people who use drugs. In particular, it focuses...

This guide is aimed at supporting teams organising stakeholder round-table meetings as part of their regional or national diagnostic processes aimed at identifying barriers to and opportunities to increase hepatitis C virus  testing and care in drug services.

This EMCDDA's hepatitis C toolkit aims to support countries in reaching the elimination goal by increasing access of people who inject drugs to testing and care through drugs services. It brings together a range of practical resources including guides, checklists, questionnaires and useful...

The elimination barometer for hepatitis B and C among people who inject drugs is designed to support countries affiliated to the EMCDDA in monitoring their progress towards the Sustainable Development Goal 3.3 and the elimination of viral hepatitis as a major public health threat by 2030. Under...